Found: 82
Select item for more details and to access through your institution.
Dupilumab in Adults With Moderate to Severe Atopic Dermatitis: A 5-Year Open-Label Extension Study.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 8, p. 805, doi. 10.1001/jamadermatol.2024.1536
- By:
- Publication type:
- Article
Association Between Atopic Dermatitis and Educational Attainment in Denmark.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Connubial tinea gladiatorum due to Trichophyton mentagrophytes.
- Published in:
- Mycoses, 2010, v. 53, n. 6, p. 533, doi. 10.1111/j.1439-0507.2009.01734.x
- By:
- Publication type:
- Article
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 3, p. 485, doi. 10.1007/s40257-024-00853-4
- By:
- Publication type:
- Article
Treat-to-Target in Atopic Dermatitis.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 1, p. 91, doi. 10.1007/s40257-023-00827-y
- By:
- Publication type:
- Article
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 1, p. 127, doi. 10.1007/s40257-023-00810-7
- By:
- Publication type:
- Article
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 3, p. 393, doi. 10.1007/s40257-022-00685-0
- By:
- Publication type:
- Article
Appraisal of Proactive Topical Therapy in Atopic Dermatitis: Pros and Cons.
- Published in:
- American Journal of Clinical Dermatology, 2021, v. 22, n. 6, p. 775, doi. 10.1007/s40257-021-00629-0
- By:
- Publication type:
- Article
Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- American Journal of Clinical Dermatology, 2020, v. 21, n. 4, p. 567, doi. 10.1007/s40257-020-00527-x
- By:
- Publication type:
- Article
Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis.
- Published in:
- American Journal of Clinical Dermatology, 2019, v. 20, n. 3, p. 443, doi. 10.1007/s40257-019-00445-7
- By:
- Publication type:
- Article
Nomenclature and clinical phenotypes of atopic dermatitis.
- Published in:
- Therapeutic Advances in Chronic Disease, 2021, p. 1, doi. 10.1177/20406223211002979
- By:
- Publication type:
- Article
Nomenclature and clinical phenotypes of atopic dermatitis.
- Published in:
- Therapeutic Advances in Chronic Disease, 2021, p. 1, doi. 10.1177/20406223211002979
- By:
- Publication type:
- Article
Non-Atopic Chronic Nodular Prurigo (Prurigo Nodularis Hyde): A Systematic Review of Best-Evidenced Treatment Options.
- Published in:
- Dermatology (10188665), 2022, v. 238, n. 5, p. 950, doi. 10.1159/000523700
- By:
- Publication type:
- Article
Emerging Treatment Options in Atopic Dermatitis: Topical Therapies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Emerging Treatment Options in Atopic Dermatitis: Systemic Therapies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The doctors' perception of skin diseases in general practice in Denmark, with emphasis on atopic dermatitis: A descriptive study.
- Published in:
- JEADV Clinical Practice, 2024, v. 3, n. 4, p. 1095, doi. 10.1002/jvc2.426
- By:
- Publication type:
- Article
Treatment and referral patterns of patients with atopic dermatitis from the Danish primary care system to the tertiary care system.
- Published in:
- JEADV Clinical Practice, 2024, v. 3, n. 4, p. 1005, doi. 10.1002/jvc2.374
- By:
- Publication type:
- Article
Atopic eczema patients and healthcare professionals join forces in Malta.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 2, p. 404, doi. 10.1002/jvc2.156
- By:
- Publication type:
- Article
Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2171, doi. 10.1007/s13555-024-01225-w
- By:
- Publication type:
- Article
Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 4, p. 1357, doi. 10.1007/s13555-021-00558-0
- By:
- Publication type:
- Article
Immunosuppressive and Immunomodulating Therapy for Atopic Dermatitis in Pregnancy: An Appraisal of the Literature.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 6, p. 1215, doi. 10.1007/s13555-020-00457-w
- By:
- Publication type:
- Article
An Emollient Containing Aquaphilus dolomiae Extract is Effective in the Management of Xerosis and Pruritus: An International, Real-World Study.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 5, p. 1013, doi. 10.1007/s13555-020-00415-6
- By:
- Publication type:
- Article
Regulation of caspase 14 expression in keratinocytes by inflammatory cytokines - a possible link between reduced skin barrier function and inflammation?
- Published in:
- Experimental Dermatology, 2011, v. 20, n. 8, p. 633, doi. 10.1111/j.1600-0625.2011.01280.x
- By:
- Publication type:
- Article
TARC augments TNF-α-induced CTACK production in keratinocytes.
- Published in:
- Experimental Dermatology, 2004, v. 13, n. 9, p. 551, doi. 10.1111/j.0906-6705.2004.00202.x
- By:
- Publication type:
- Article
Thymus- and activation-regulated chemokine ( TARC/CCL17) induces a Th<sub>2</sub>-dominated inflammatory reaction on intradermal injection in mice.
- Published in:
- Experimental Dermatology, 2004, v. 13, n. 4, p. 265, doi. 10.1111/j.0906-6705.2004.00149.x
- By:
- Publication type:
- Article
Advances in the Diagnosis and Therapeutic Management of Atopic Dermatitis.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Linkage of atopic dermatitis to chromosomes 4q22, 3p24 and 3q21.
- Published in:
- Human Genetics, 2009, v. 126, n. 4, p. 549, doi. 10.1007/s00439-009-0692-z
- By:
- Publication type:
- Article
695 - Long-term dupilumab treatment is not associated with an increased overall risk of infections in adults with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.069
- By:
- Publication type:
- Article
Treatment efficacy in patients with moderate-to-severe atopic dermatitis who switched from dupilumab to abrocitinib in JADE EXTEND, a phase 3 long-term extension study.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii32, doi. 10.1093/bjd/ljad498.035
- By:
- Publication type:
- Article
Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 2, p. 238, doi. 10.1093/bjd/ljad124
- By:
- Publication type:
- Article
423 Long-term efficacy of abrocitinib up to 96 weeks in adults with moderate-to-severe atopic dermatitis stratified by age: a post hoc analysis of the JADE EXTEND phase 3 trial.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.043
- By:
- Publication type:
- Article
416 Long-term efficacy of dupilumab in adults with moderate-to-severe atopic dermatitis: results from an open-label extension trial up to 5 years.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.036
- By:
- Publication type:
- Article
417 Safety of long-term dupilumab treatment in adults with moderate-to-severe atopic dermatitis: results from an open-label extension trial up to 5 years.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.037
- By:
- Publication type:
- Article
410 Dupilumab treatment reduces total IgE levels in patients 6 months and older with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.031
- By:
- Publication type:
- Article
Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome Manifesting as Lymphocytic Interstitial Pneumonia and Treatment-Resistant Bullous Pemphigoid.
- Published in:
- Pediatric Allergy, Immunology & Pulmonology, 2021, v. 34, n. 2, p. 76, doi. 10.1089/ped.2020.1307
- By:
- Publication type:
- Article
Attention-Deficit/Hyperactivity Disorder in Atopic Dermatitis: An Appraisal of the Current Literature.
- Published in:
- Pediatric Allergy, Immunology & Pulmonology, 2016, v. 29, n. 4, p. 181, doi. 10.1089/ped.2016.0705
- By:
- Publication type:
- Article
A genome-wide search for linkage to allergic rhinitis in Danish sib-pair families.
- Published in:
- European Journal of Human Genetics, 2012, v. 20, n. 9, p. 965, doi. 10.1038/ejhg.2012.46
- By:
- Publication type:
- Article
Therapy of severe atopic dermatitis in adults.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2012, v. 10, n. 6, p. 399, doi. 10.1111/j.1610-0387.2012.07899.x
- By:
- Publication type:
- Article
Therapie der schweren atopischen Dermatitis bei Erwachsenen.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2012, v. 10, n. 6, p. 399, doi. 10.1111/j.1610-0387.2012.07899_suppl.x
- By:
- Publication type:
- Article
Allergic contact dermatitis in Danish children referred for patch testing - a nationwide multicentre study.
- Published in:
- Contact Dermatitis (01051873), 2014, v. 70, n. 2, p. 104, doi. 10.1111/cod.12129
- By:
- Publication type:
- Article
Contact allergy and allergic contact dermatitis in children - a review of current data.
- Published in:
- Contact Dermatitis (01051873), 2011, v. 65, n. 5, p. 254, doi. 10.1111/j.1600-0536.2011.01963.x
- By:
- Publication type:
- Article
Methylprednisolone Therapy in Acute Hemorrhagic Edema of Infancy.
- Published in:
- Case Reports in Dermatological Medicine, 2014, p. 1, doi. 10.1155/2014/853038
- By:
- Publication type:
- Article
Omalizumab Induced Remission of Idiopathic Anaphylaxis in a Patient Suffering from Indolent Systemic Mastocytosis.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Abatacept is a Promising Treatment for Patients with Disseminated Morphea Profunda: Presentation of Two Cases.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
A Retrospective Study of Six Cases of Severe Recalcitrant Atopic Dermatitis rureated with Long- term Extracorporeal Photopheresis.
- Published in:
- Acta Dermato-Venereologica, 2010, v. 90, n. 6, p. 635, doi. 10.2340/00015555-0952
- By:
- Publication type:
- Article
Two Cases of Severe Refractory Chronic Idiopathic Urticaria Treated with Omalizumab.
- Published in:
- 2010
- By:
- Publication type:
- Letter
T-cell Receptor Excision Circles (TREC) in CD4 + and CD8 + T-cell Subpopulations in Atopic Dermatitis and Psoriasis Show Major Differences in the Emission of Recent Thymic Emigrants.
- Published in:
- Acta Dermato-Venereologica, 2008, v. 88, n. 6, p. 566, doi. 10.2340/00015555-0550
- By:
- Publication type:
- Article
Concomitant Sweet's Syndrome and Relapsing Polychondritis.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Glucocorticoid-induced Tumour Necrosis Factor Receptor (GITR) and its Ligand (GITRL) in Atopic Dermatitis.
- Published in:
- Acta Dermato-Venereologica, 2006, v. 86, n. 5, p. 393, doi. 10.2340/00015555-0118
- By:
- Publication type:
- Article
Clonal Spread of Staphylococcus aureus with Reduced Susceptibility to Oxacillin in a Dermatological Hospital Unit.
- Published in:
- Acta Dermato-Venereologica, 2006, v. 86, n. 3, p. 230, doi. 10.2340/00015555-0072
- By:
- Publication type:
- Article